• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

Comprehensive Analysis of Ethyl 14(Z)-Tricosenoate (CAS No. 2692622-89-0): Properties, Applications, and Industry Trends

Ethyl 14(Z)-Tricosenoate (CAS No. 2692622-89-0) is a specialized fatty acid ester gaining attention in pharmaceutical, cosmetic, and biochemical research due to its unique structural properties. As a Z-configuration unsaturated ester, it exhibits distinct physicochemical characteristics, including lower melting points and enhanced solubility compared to saturated analogs. This compound belongs to the long-chain ethyl esters family, a class increasingly studied for their bioactivity and formulation benefits.

The 14(Z)-tricosenoate moiety is notable for its cis-double bond at the 14th carbon, which influences molecular flexibility and interaction with biological membranes. Researchers are exploring its potential as a lipid-based drug carrier, leveraging its ability to improve bioavailability of poorly soluble APIs. In cosmetic science, its emollient properties and oxidative stability make it a candidate for advanced skincare formulations, particularly in anti-aging products where lipid barrier repair is crucial.

Current market trends show growing demand for sustainable specialty esters, with Ethyl 14(Z)-Tricosenoate positioned as a potential bio-based alternative to synthetic emollients. Analytical techniques like HPLC-UV and GC-MS are essential for quality control, given the compound's sensitivity to cis-trans isomerization during processing. The pharmaceutical industry particularly values its high purity grades (>98%) for liposome formulation studies.

From a synthetic chemistry perspective, 2692622-89-0 presents challenges in stereoselective synthesis, with modern approaches employing cross-metathesis or Wittig olefination strategies. Its structure-activity relationships are being investigated for potential anti-inflammatory effects, with preliminary studies suggesting modulation of PPAR-γ pathways. These findings align with the growing scientific interest in lipid mediators and their therapeutic applications.

In material science, the compound's self-assembly properties are being examined for nanostructured lipid carriers. Its C23 backbone provides optimal chain length for certain membrane interactions, making it valuable for biomimetic research. Recent patents highlight its incorporation in transdermal delivery systems, where its enhanced skin permeation characteristics outperform shorter-chain esters.

Environmental considerations are shaping production methods for Ethyl 14(Z)-Tricosenoate, with green chemistry principles being applied to reduce solvent waste. The compound's biodegradability profile makes it attractive for eco-friendly formulations, responding to regulatory pressures on persistent organic compounds. Analytical challenges include developing robust stability-indicating methods to monitor oxidative degradation during storage.

Future research directions focus on structure optimization to enhance its biological half-life while maintaining favorable toxicological profiles. The compound's structure-property relationships are providing insights for designing next-generation lipid excipients. As analytical techniques advance, particularly in mass spectrometry imaging, new applications in targeted drug delivery may emerge for this versatile lipid ester.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)